Madrigal Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MDGL
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.
CEOWilliam J. Sibold
CEOWilliam J. Sibold
Employees528
Employees528
HeadquartersWest Conshohocken, Pennsylvania
HeadquartersWest Conshohocken, Pennsylvania
Founded2000
Founded2000
Employees528
Employees528
MDGL Key Statistics
Market cap7.42B
Market cap7.42B
Price-Earnings ratio-19.33
Price-Earnings ratio-19.33
Dividend yield—
Dividend yield—
Average volume349.66K
Average volume349.66K
High today$350.19
High today$350.19
Low today$331.24
Low today$331.24
Open price$349.99
Open price$349.99
Volume321.62K
Volume321.62K
52 Week high$377.46
52 Week high$377.46
52 Week low$200.63
52 Week low$200.63
Analyst ratings
88%
of 16 ratingsBuy
87.5%
Hold
6.3%
Sell
6.3%
People also own
Based on the portfolios of people who own MDGL. This list is generated using Robinhood data, and it’s not a recommendation.